1. Corporate Officers - M
2. Miller Ann Calby

Insider Trading History of Miller Ann Calby

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Miller Ann Calby since 2020. This trader's CIK number is 1771423. At the time of last reporting, Miller Ann Calby was the Director of Inovio Pharmaceuticals, Inc.. (stock ticker symbol INO). Also see all insider trading activities at Inovio Pharmaceuticals, Inc..

Note that in the past Miller Ann Calby also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Puma Biotechnology, Inc. (PBYI) by Miller Ann Calby

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	PBYI	0	$0	12,874	$147,162	0	$0

Yearly summary of insider trading at Inovio Pharmaceuticals, Inc. (INO) by Miller Ann Calby

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	INO	0	$0	0	$0	2,167	$0
2024	INO	0	$0	0	$0	2,166	$0
2023	INO	0	$0	0	$0	19,000	$0
2022	INO	0	$0	0	$0	22,273	$0
2021	INO	0	$0	0	$0	12,974	$0
2020	INO	0	$0	0	$0	12,287	$0

Insider trading activities at 2 companies by Miller Ann Calby:

1. Puma Biotechnology, Inc. (PBYI)

2. Inovio Pharmaceuticals, Inc. (INO)

Table 1. Insider trading of Puma Biotechnology, Inc. (PBYI) by Miller Ann Calby

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-06-10	PBYI	Sale	12,874	11.43	147,162

Table 2. Insider trading of Inovio Pharmaceuticals, Inc. (INO) by Miller Ann Calby

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-05-21	INO	Option Ex	2,167	.00	0
2024-05-15	INO	Option Ex	2,166	.00	0
2023-05-16	INO	Option Ex	19,000	.00	0
2022-05-13	INO	Option Ex	18,000	.00	0
2022-03-21	INO	Option Ex	4,273	.00	0
2021-05-14	INO	Option Ex	8,700	.00	0
2021-03-21	INO	Option Ex	4,274	.00	0
2020-05-08	INO	Option Ex	8,013	.00	0
2020-03-21	INO	Option Ex	4,274	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miller Ann Calby (Director of Inovio Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month